Financial News · Live Terminal

Page 1043 of 1177

Alleanza to Hold EGM to Vote on Share Consolidation

Alleanza Holdings (TYO:3546) will hold an extraordinary shareholders' meeting on May 27 to approve a share consolidation and related changes, which will lead to its delisting from the Tokyo Stock Exchange, according to a Thursday filing on the Tokyo Stock Exchange.The shares will be designated for delisting from May 27 to June 25 and are set to be removed on June 26.The move follows a tender offer by Kohnan Shoji (TYO:7516), which acquired 38.8% of voting rights, as part of steps to make the company a wholly owned subsidiary.

Financial News · Live Terminal

Alleanza to Hold EGM to Vote on Share Consolidation

Shenzhen Expressway to Terminate Toll Collection on Shenzhen City Expressway

Jarden Adjusts Bank of Queensland's Price Target to AU$5.50 from AU$6, Keeps at Sell

J-Yuan Trust's Profit Surges 120% in 2025

Jarden Adjusts Cochlear's Price Target to AU$169 from AU$224, Keeps at Neutral

Jarden Adjusts Northern Star Resources' Price Target to AU$22.30 from AU$22.50, Keeps at Underweight

Bank of The Ryukyus Logs 3.29 Billion Yen in Unrealized Loss on Held-to-Maturity Bonds

Media Do Increases Final Dividend

Nomura Adjusts Medco Energi Internasional's Price Target to IDR2,600 From IDR1,900, Keeps at Buy

Nomura Adjusts Ciputra Development's Price Target to IDR1,070 From IDR1,500, Keeps at Buy

Nomura Adjusts Akeso's Price Target to HK$142.75 From HK$112.73, Keeps at Neutral

Beijing Victory Electric Launches Shenzhen IPO

Nomura Adjusts Contemporary Amperex Technology's Price Target to 612 Yuan From 476 Yuan, Keeps at Buy

Nomura Adjusts Samsung Biologics' Price Target to KRW2,200,000 From KRW2,600,000, Keeps at Buy

Nomura Adjusts SBI Life Insurance's Price Target to INR2,440 From INR2,455, Keeps at Buy

Nomura Adjusts Havells India's Price Target to INR1,620 From INR1,798, Keeps at Buy

Nomura Adjusts Yifeng Pharmacy Chain's Price Target to 35.50 Yuan From 34.18 Yuan, Keeps at Buy

Visional Allocates Stock Options to Four Directors

Bank of The Ryukyus Raises Annual Earnings Forecast

Freee Plans 15 Billion Yen Capital Cut

Alleanza to Hold EGM to Vote on Share Consolidation

Shenzhen Expressway to Terminate Toll Collection on Shenzhen City Expressway

Jarden Adjusts Bank of Queensland's Price Target to AU$5.50 from AU$6, Keeps at Sell

J-Yuan Trust's Profit Surges 120% in 2025

Jarden Adjusts Cochlear's Price Target to AU$169 from AU$224, Keeps at Neutral

Jarden Adjusts Northern Star Resources' Price Target to AU$22.30 from AU$22.50, Keeps at Underweight

Bank of The Ryukyus Logs 3.29 Billion Yen in Unrealized Loss on Held-to-Maturity Bonds

Media Do Increases Final Dividend

Nomura Adjusts Medco Energi Internasional's Price Target to IDR2,600 From IDR1,900, Keeps at Buy

Nomura Adjusts Ciputra Development's Price Target to IDR1,070 From IDR1,500, Keeps at Buy

Nomura Adjusts Akeso's Price Target to HK$142.75 From HK$112.73, Keeps at Neutral

Beijing Victory Electric Launches Shenzhen IPO

Nomura Adjusts Contemporary Amperex Technology's Price Target to 612 Yuan From 476 Yuan, Keeps at Buy

Nomura Adjusts Samsung Biologics' Price Target to KRW2,200,000 From KRW2,600,000, Keeps at Buy

Nomura Adjusts SBI Life Insurance's Price Target to INR2,440 From INR2,455, Keeps at Buy

Nomura Adjusts Havells India's Price Target to INR1,620 From INR1,798, Keeps at Buy

Nomura Adjusts Yifeng Pharmacy Chain's Price Target to 35.50 Yuan From 34.18 Yuan, Keeps at Buy

Visional Allocates Stock Options to Four Directors

Bank of The Ryukyus Raises Annual Earnings Forecast

Freee Plans 15 Billion Yen Capital Cut